Parkman Healthcare Partners’s Akoya BioSciences AKYA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-376,131
| Closed | -$1.02M | – | 91 |
|
|
2024
Q3 | $1.02M | Buy |
376,131
+595
| +0.2% | +$1.62K | 0.13% | 85 |
|
|
2024
Q2 | $879K | Sell |
375,536
-541,906
| -59% | -$1.27M | 0.12% | 80 |
|
|
2024
Q1 | $4.3M | Buy |
917,442
+242,655
| +36% | +$1.14M | 0.53% | 63 |
|
|
2023
Q4 | $3.29M | Buy |
674,787
+149,164
| +28% | +$728K | 0.46% | 65 |
|
|
2023
Q3 | $2.44M | Buy |
525,623
+54,623
| +12% | +$254K | 0.45% | 64 |
|
|
2023
Q2 | $3.48M | Buy |
471,000
+269,615
| +134% | +$1.99M | 0.6% | 54 |
|
|
2023
Q1 | $1.65M | Buy |
201,385
+60,130
| +43% | +$492K | 0.36% | 64 |
|
|
2022
Q4 | $1.35M | Sell |
141,255
-20,446
| -13% | -$196K | 0.36% | 66 |
|
|
2022
Q3 | $1.9M | Sell |
161,701
-23,084
| -12% | -$271K | 0.54% | 58 |
|
|
2022
Q2 | $2.37M | Buy |
184,785
+34,464
| +23% | +$443K | 0.87% | 39 |
|
|
2022
Q1 | $1.65M | Buy |
150,321
+25,321
| +20% | +$278K | 0.48% | 53 |
|
|
2021
Q4 | $1.91M | Buy |
+125,000
| New | +$1.91M | 0.42% | 60 |
|